- FASTA Sequence
- PDBx/mmCIF Format
- PDBx/mmCIF Format (gz)
- BinaryCIF Format (gz)
- Legacy PDB Format
- Legacy PDB Format (gz)
- PDBML/XML Format (gz)
- Structure Factors (CIF)
- Structure Factors (CIF - gz)
- Validation Full (PDF - gz)
- Validation (XML - gz)
- Validation (CIF - gz)
- Validation 2fo-fc coefficients (CIF - gz)
- Validation fo-fc coefficients (CIF - gz)
- Biological Assembly 1 (CIF - gz)
- Biological Assembly 1 (PDB - gz)
1R4L | pdb_00001r4l
Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2)
- PDB DOI: https://doi.org/10.2210/pdb1R4L/pdb
- Classification: HYDROLASE
- Organism(s): Homo sapiens
- Expression System: Spodoptera frugiperda
- Mutation(s): No
- Deposited: 2003-10-07 Released: 2004-02-03
- Deposition Author(s): Towler, P., Staker, B., Prasad, S.G., Menon, S., Ryan, D., Tang, J., Parsons, T., Fisher, M., Williams, D., Dales, N.A., Patane, M.A., Pantoliano, M.W.
Experimental Data Snapshot
- Method: X-RAY DIFFRACTION
- Resolution: 3.00 Å
- R-Value Free: 0.337 (Depositor), 0.329 (DCC)
- R-Value Work: 0.253 (Depositor), 0.243 (DCC)
Starting Model: experimental
View more details
Literature
- 👁 Image
Download Mendeley
ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis.
Towler, P., Staker, B., Prasad, S.G., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N.A., Patane, M.A., Pantoliano, M.W.(2004) J Biological Chem 279: 17996-18007
- PubMed: 14754895 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1074/jbc.M311191200
- Primary Citation Related Structures:
1R42, 1R4L - PubMed Abstract:
The angiotensin-converting enzyme (ACE)-related carboxypeptidase, ACE2, is a type I integral membrane protein of 805 amino acids that contains one HEXXH + E zinc-binding consensus sequence. ACE2 has been implicated in the regulation of heart function and also as a functional receptor for the coronavirus that causes the severe acute respiratory syndrome (SARS). To gain further insights into this enzyme, the first crystal structures of the native and inhibitor-bound forms of the ACE2 extracellular domains were solved to 2.2- and 3.0-A resolution, respectively. Comparison of these structures revealed a large inhibitor-dependent hinge-bending movement of one catalytic subdomain relative to the other ( approximately 16 degrees ) that brings important residues into position for catalysis. The potent inhibitor MLN-4760 ((S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol4-yl]-ethylamino]-4-methylpentanoic acid) makes key binding interactions within the active site and offers insights regarding the action of residues involved in catalysis and substrate specificity. A few active site residue substitutions in ACE2 relative to ACE appear to eliminate the S(2)' substrate-binding subsite and account for the observed reactivity change from the peptidyl dipeptidase activity of ACE to the carboxypeptidase activity of ACE2.
- Drug Discovery and Protein Sciences, Millennium Pharmaceuticals, Incorporated, Cambridge, Massachusetts 02139, USA.
Organizational Affiliation:
Explore in 3D: Structure | Sequence Annotations | Electron Density | Validation Report | Ligand Interaction (XX5)
Biological Assembly 1
Explore in 3D: Structure | Sequence Annotations | Electron Density | Validation Report | Ligand Interaction (XX5)
Global Symmetry: Asymmetric - C1
Global Stoichiometry: Hetero 5-mer - A2B1C1D1
Pseudo Symmetry: Asymmetric - C1
Pseudo Stoichiometry: Hetero 5-mer - A1B1C1D1E1
Find Similar Assemblies
Biological assembly 1 assigned by authors.
Macromolecule Content
- Total Structure Weight: 76.98 kDa
- Atom Count: 5,218
- Modeled Residue Count: 655
- Deposited Residue Count: 673
- Unique protein chains: 5
Macromolecules
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| angiotensin I converting enzyme 2 | 615 | Homo sapiens | Mutation(s): 0 Gene Names: ACE2 EC: 3.4.17 (UniProt), 3.4.17.23 (UniProt) | 👁 Image | |
UniProt & NIH Common Fund Data Resources | |||||
PHAROS: Q9BYF1 GTEx: ENSG00000130234 | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | Q9BYF1 | ||||
Glycosylation | |||||
| Glycosylation Sites: 2 | Go to GlyGen: Q9BYF1-1 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| disordered segment of collectrin homology domain | 6 | Homo sapiens | Mutation(s): 0 Gene Names: ACE2 | 👁 Image | |
Entity ID: 3 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| disordered segment of collectrin homology domain | 20 | Homo sapiens | Mutation(s): 0 Gene Names: ACE2 | 👁 Image | |
Entity ID: 4 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| disordered segment of collectrin homology domain | 18 | Homo sapiens | Mutation(s): 0 Gene Names: ACE2 | 👁 Image | |
Entity ID: 5 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| disordered segment of collectrin homology domain | 14 | Homo sapiens | Mutation(s): 0 Gene Names: ACE2 | 👁 Image | |
Small Molecules
| Ligands 4 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| XX5 Download:Ideal Coordinates CCD File | J [auth A] | (S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO-BENZYL)-3H-IMIDAZOL-4-YL]-ETHYLAMINO}-4-METHYL-PENTANOIC ACID C19 H23 Cl2 N3 O4 NTCCRGGIJNDEAB-IRXDYDNUSA-N | 👁 Image | ||
| NAG Download:Ideal Coordinates CCD File | F [auth A], G [auth A] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | 👁 Image | ||
| ZN Download:Ideal Coordinates CCD File | I [auth A] | ZINC ION Zn PTFCDOFLOPIGGS-UHFFFAOYSA-N | 👁 Image | ||
| CL Download:Ideal Coordinates CCD File | H [auth A] | CHLORIDE ION Cl VEXZGXHMUGYJMC-UHFFFAOYSA-M | 👁 Image | ||
Experimental Data & Validation
Experimental Data
- Method: X-RAY DIFFRACTION
- Resolution: 3.00 Å
- R-Value Free: 0.337 (Depositor), 0.329 (DCC)
- R-Value Work: 0.253 (Depositor), 0.243 (DCC)
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 100.531 | α = 90 |
| b = 86.509 | β = 103.65 |
| c = 105.858 | γ = 90 |
| Software Name | Purpose |
|---|---|
| CNX | refinement |
| SCALEPACK | data scaling |
| AMoRE | phasing |
Entry History
Deposition Data
- Released Date: 2004-02-03 Deposition Author(s): Towler, P., Staker, B., Prasad, S.G., Menon, S., Ryan, D., Tang, J., Parsons, T., Fisher, M., Williams, D., Dales, N.A., Patane, M.A., Pantoliano, M.W.
Revision History (Full details and data files)
- Version 1.0: 2004-02-03
Type: Initial release - Version 1.1: 2008-04-29
Changes: Version format compliance - Version 1.2: 2011-07-13
Changes: Non-polymer description, Version format compliance - Version 1.3: 2020-07-29
Type: Remediation
Reason: Carbohydrate remediation
Changes: Advisory, Data collection, Derived calculations, Structure summary - Version 1.4: 2023-08-23
Changes: Data collection, Database references, Refinement description, Structure summary - Version 1.5: 2024-11-20
Changes: Structure summary
